Industry News
Cancer-Related Pathway Reveals Potential Treatment Target For Rare Pediatric Disease Cherubism
Dec 12, 2011
Cancer researchers studying genetic mutations that cause leukemia have discovered a connection to the rare disease cherubism, an inherited facial bone disorder in children. The link is the enzyme Tankyrase and its pivotal role in switching on or off the protein that controls two known cancer genes. In normal cells, the protein is vital for bone development... Read More
Breaking Oncogene's Hold On Cancer Cell Provides New Treatment Direction
Dec 12, 2011
Just as people's bodies and minds can become addicted to substances such as drugs, caffeine, alcohol, their cancers can become addicted to certain genes that insure their continued growth and dominance. Researchers at Baylor College of Medicine and Harvard Medical School have developed ways to exploit the addictions of cancers to kill them without harming normal tissues... Read More
Scientists Capture Single Cancer Molecules At Work
Dec 12, 2011
Researchers have revealed how a molecule called telomerase contributes to the control of the integrity of our genetic code, and when it is involved in the deregulation of the code, its important role in the development of cancer... Read More
New Target Found For Aggressive Myc-Driven Cancers
Dec 12, 2011
Researchers have found a way to kill human cells hijacked by a genetic accelerator that puts cancer cells into overdrive: the Myc oncogene. The discovery reveals new drug targets for Myc-driven cancers, which tend to be particularly aggressive. The results were published online December 8 in Science... Read More
Risk For Developing New Cancer In Other Breast Increased For Survivors With BRCA Mutation
Dec 12, 2011
Breast cancer survivors who carry the BRCA1 or BRCA2 genetic mutation are at high risk for developing contralateral breast cancer - a new primary tumor in the other breast - and certain women within this group of carriers are at an even greater risk based on age at diagnosis and first tumor status, according to data presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec... Read More
Many Women Do Not Undergo Breast Reconstruction After Mastectomy
Dec 12, 2011
Despite the benefits, only a small minority of women, regardless of age, are opting for immediate reconstructive breast surgery after undergoing mastectomy for treatment of breast cancer, according to data presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011... Read More
Starch Intake May Influence Risk For Breast Cancer Recurrence
Dec 12, 2011
Researchers have linked increased starch intake to a greater risk for breast cancer recurrence, according to results presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011. "The results show that it's not just overall carbohydrates, but particularly starch," said Jennifer A. Emond, M.S... Read More
Addition Of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese And Normal-Weight Patients
Dec 12, 2011
A large, multicenter, randomized study has shown that obese patients with HER2-positive breast cancer have larger tumors, increased lymph node involvement and, when not treated with trastuzumab, poorer long-term outcomes than normal-weight patients. This is the first time the relationship between obesity and HER2-positive breast cancer has been studied, according to Jennifer A. Crozier, M.D... Read More
MRI May Be Noninvasive Method To Measure Breast Cancer Prognosis
Dec 12, 2011
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients to appropriate therapies, according to preliminary data presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011... Read More
Similar Blood Pressure Drugs Could Have Different Impacts On Dialysis Patients' Heart Health
Dec 11, 2011
Two seemingly similar blood pressure - lowering drugs have different effects on the heart health of dialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that certain dialysis patients may benefit more from one drug while some should opt for the other... Read More
Previous Page Next Page